Literature DB >> 9858220

Chromosomal abnormalities in systemic amyloidosis.

R Fonseca1, G J Ahmann, S M Jalal, G W Dewald, D R Larson, T M Therneau, M A Gertz, R A Kyle, P R Greipp.   

Abstract

Primary systemic amyloidosis (AL) is a plasma cell disorder characterized by deposition of monoclonal light chains in different organ systems. Although multiple and complex numerical chromosomal abnormalities have been described in patients with multiple myeloma, it is currently unknown whether such changes occur in systemic amyloidosis. Bone marrow samples from 21 patients with AL were studied by standard cytogenetics and interphase fluorescence in situ hybridization (FISH) for the presence of numerical chromosomal abnormalities. We tested for six chromosomes (7, 11, 9, 15, 18 and X) using centromere-specific probes. The monoclonal plasma cells were identified by simultaneous fluorescent staining of the monotypic cytoplasmic immunoglobulin. We compared these results with those obtained from 19 patients with monoclonal gammopathy of undetermined significance (MGUS) and normal controls. Multiple numerical chromosomal abnormalities were detected in AL by interphase FISH, including trisomy of chromosomes 7 (42%), 9 (52%), 11 (47%), 15 (39%), 18 (33%) and X (13% in women and 54% in men). Monosomy of chromosome 18 was seen in 72% of cases. Previous exposure to alkylator therapy did not appear to correlate with these abnormalities. No significant difference was observed in the prevalence of these abnormalities between AL and MGUS. Multiple chromosomal numerical abnormalities were detected by interphase FISH analysis in patients with AL, especially monosomy of chromosome 18. Aneuploidy in the monotypic plasma supports a neoplastic nature for the disorder.

Entities:  

Mesh:

Year:  1998        PMID: 9858220     DOI: 10.1046/j.1365-2141.1998.01034.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Increased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis.

Authors:  Brendan M Weiss; Joseph Hebreo; Daniel V Cordaro; Mark J Roschewski; Thomas P Baker; Kevin C Abbott; Stephen W Olson
Journal:  J Clin Oncol       Date:  2014-07-14       Impact factor: 44.544

2.  Amyloidosis: The Newer Discovered ALECT2 Associated with der7q add(7).

Authors:  Amrita Chakrabarti; Priyanka Samal; Joydeep Chakrabartty
Journal:  J Clin Diagn Res       Date:  2016-09-01

3.  A 70-Year-Old Man With Large Cervical and Mediastinal Lymphadenopathies.

Authors:  Shraddha Narechania; Jason Valent; Carol Farver; Adriano R Tonelli
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

4.  Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.

Authors:  Alan H Bryce; Rhett P Ketterling; Morie A Gertz; Martha Lacy; Ryan A Knudson; Steven Zeldenrust; Shaji Kumar; Suzanne Hayman; Francis Buadi; Robert A Kyle; Philip R Greipp; John A Lust; Stephen Russell; S Vincent Rajkumar; Rafael Fonseca; Angela Dispenzieri
Journal:  Haematologica       Date:  2009-02-11       Impact factor: 9.941

5.  Amiloidosis, a mysterious disease, still underestimated.

Authors:  Mircea Penescu
Journal:  J Med Life       Date:  2008 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.